ATI Inc. (NYSE: ATI) reported second quarter 2025 results, with sales of $1.14 billion and net income attributable to ATI of $100.7 million, or $0.70 per share.

Japanese patient cohort enrollment is completed ahead of schedule at multiple clinical sites including the National Cancer ...